{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T12:14:06Z","timestamp":1775477646234,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T00:00:00Z","timestamp":1491350400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s12098-017-2318-0","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T12:24:23Z","timestamp":1491395063000},"page":"382-392","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Management of Non-Hodgkin Lymphoma: ICMR Consensus Document"],"prefix":"10.1007","volume":"84","author":[{"given":"Nirav","family":"Thacker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer","family":"Bakhshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girish","family":"Chinnaswamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tushar","family":"Vora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Agarwala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gauri","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkatraman","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddharth","family":"Laskar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanvir","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. K.","family":"Rath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupinder Singh","family":"Dhaliwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brijesh","family":"Arora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,5]]},"reference":[{"key":"2318_CR1","unstructured":"Kulkarni KP, Arora RS, Arora B. Current outcomes of childhood Non Hodgkin lymphoma in India: results of a systematic review. Abstracts of the 45th Congress of the International Society of Paediatric Oncology (SIOP) 2013. Hong Kong, China. September 25\u201328, 2013.Pediatr Blood Cancer. 2013;60:S80. Abstract nr P-0110."},{"key":"2318_CR2","doi-asserted-by":"publisher","first-page":"264","DOI":"10.4103\/0019-509X.55546","volume":"46","author":"RS Arora","year":"2009","unstructured":"Arora RS, Eden TO, Kapoor G. Epidemiology of childhood cancer in India. Indian J Cancer. 2009;46:264\u201373.","journal-title":"Indian J Cancer"},{"key":"2318_CR3","unstructured":"Three year report of the population based cancer registries 2009\u20132011: Report of 25 PBCRs; National Cancer Registry Programme, Indian Council Medical Research, Bangalore 2013. Available at: URL: http:\/\/ncrpindia.org\/Reports\/PBCR_2009_2011.aspx . Accessed on 14 Jul 2015."},{"key":"2318_CR4","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1093\/annonc\/11.suppl_1.S63","volume":"11","author":"KN Naresh","year":"2000","unstructured":"Naresh KN, Srinivas V, Soman CS. Distribution of various subtypes of non-Hodgkin\u2019s lymphoma in India: a study of 2773 lymphomas using R.E.A.L. and WHO classifications. Ann Oncol. 2000;11:S63\u20137.","journal-title":"Ann Oncol"},{"key":"2318_CR5","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1200\/JCO.1989.7.2.186","volume":"7","author":"SB Murphy","year":"1989","unstructured":"Murphy SB, Fairclough DL, Hutchison RE, Berard CW. Non-Hodgkin's lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution. J Clin Oncol. 1989;7:186\u201393.","journal-title":"J Clin Oncol"},{"key":"2318_CR6","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1200\/JCO.2014.59.7203","volume":"33","author":"A Rosolen","year":"2015","unstructured":"Rosolen A, Perkins SL, Pinkerton CR, et al. Revised international pediatric non-Hodgkin lymphoma staging system. J Clin Oncol. 2015;33:2112\u20138.","journal-title":"J Clin Oncol"},{"key":"2318_CR7","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2006-07-036673","volume":"109","author":"C Patte","year":"2007","unstructured":"Patte C, Auperin A, Gerrard M, et al. Results of the randomized international FAB\/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood. 2007;109:2773\u201380.","journal-title":"Blood"},{"key":"2318_CR8","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1182\/blood-2006-07-036665","volume":"109","author":"MS Cairo","year":"2007","unstructured":"Cairo MS, Gerrard M, Sposto R, et al. Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents. Blood. 2007;109:2736\u201343.","journal-title":"Blood"},{"key":"2318_CR9","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/j.1365-2141.2008.07144.x","volume":"141","author":"M Gerrard","year":"2008","unstructured":"Gerrard M, Cairo MS, Weston C, et al. Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin\u2019s lymphoma: results of the FAB\/LMB 96 international study. Br J Haematol. 2008;141:840\u20137.","journal-title":"Br J Haematol"},{"key":"2318_CR10","first-page":"3294","volume":"94","author":"A Reiter","year":"1999","unstructured":"Reiter A, Schrappe M, Tiemann M, et al. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the berlin-Frankfurt-M\u00fcnster group trial NHL-BFM 90. Blood. 1999;94:3294\u2013306.","journal-title":"Blood"},{"key":"2318_CR11","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1182\/blood-2007-07-100958","volume":"111","author":"MC Le Deley","year":"2008","unstructured":"Le Deley MC, Reiter A, Williams D, et al. Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup study. Blood. 2008;111:1560\u20136.","journal-title":"Blood"},{"key":"2318_CR12","first-page":"795","volume":"22","author":"M Gerrard","year":"2003","unstructured":"Gerrard M, Cairo MS, Weston C, et al. Results of the FAB LMB 96 international study in children and adolescents (C\u00a0+\u00a0A) with localised, resected B cell lymphoma (large cell [LCL], Burkitt\u2019s [BL] and Burkitt-like [BLL]). Proc Am Soc Clin Oncol. 2003;22:795.","journal-title":"Proc Am Soc Clin Oncol"},{"key":"2318_CR13","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s12098-014-1606-1","volume":"82","author":"S Jayabose","year":"2015","unstructured":"Jayabose S, Kumar V, Dhanabalan R, Rajan P, Rathnam K, Viswanathan TK. Low-dose rasburicase in hematologic malignancies. Indian J Pediatr. 2015;82:458\u201361.","journal-title":"Indian J Pediatr"},{"key":"2318_CR14","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1182\/blood-2004-03-0973","volume":"105","author":"W Woessmann","year":"2005","unstructured":"Woessmann W, Seidemann K, Mann G, et al. The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM group study NHL-BFM95. Blood. 2005;105:948\u201358.","journal-title":"Blood"},{"key":"2318_CR15","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1056\/NEJM199710303371802","volume":"337","author":"MP Link","year":"1997","unstructured":"Link MP, Shuster JJ, Donaldson SS, et al. Treatment of children and young adults with early-stage non-Hodgkin\u2019s lymphoma. N Engl J Med. 1997;337:1259\u201366.","journal-title":"N Engl J Med"},{"key":"2318_CR16","unstructured":"Arora B, Kaur U, Gulia S, et al. Modified MCP-842: a novel highly efficacious, safe and cost-effective protocol for B-NHL treatment in resource poor countries. Proceedings of the Third International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma, June 2009. Frankfurt, Germany."},{"key":"2318_CR17","doi-asserted-by":"crossref","first-page":"A","DOI":"10.1200\/JCO.2016.34.15_suppl.10507","volume":"34","author":"V Minard-Colin","year":"2016","unstructured":"Minard-Colin V, Auperin A, Pillon M, et al. Results of the randomized intergroup trial Inter-B-NHL Ritux 2010 for children and adolescents with high-risk B-cell non-Hodgkin lymphoma (B-NHL) and mature acute leukemia (B-AL): evaluation of rituximab (R) efficacy in addition to standard LMB chemotherapy (CT) regimen [Abstract]. J Clin Oncol. 2016;34:A\u201310507.","journal-title":"J Clin Oncol"},{"key":"2318_CR18","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1046\/j.1365-2141.2001.02647.x","volume":"112","author":"A Atra","year":"2001","unstructured":"Atra A, Gerrard M, Hobson R, et al. Outcome of relapsed or refractory childhood B-cell acute lymphoblastic leukaemia and B-cell non-Hodgkin\u2019s lymphoma treated with the UKCCSG 9003\/9002 protocols. Br J Haematol. 2001;112:965\u20138.","journal-title":"Br J Haematol"},{"key":"2318_CR19","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1200\/JCO.2001.19.9.2390","volume":"19","author":"NL Kobrinsky","year":"2001","unstructured":"Kobrinsky NL, Sposto R, Shah NR, et al. Outcomes of treatment of children and adolescents with recurrent non-Hodgkin\u2019s lymphoma and Hodgkin\u2019s disease with dexamethasone, etoposide, cisplatin, cytarabine, and l-asparaginase, maintenance chemotherapy, and transplantation: Children\u2019s cancer group study CCG-5912. J Clin Oncol. 2001;19:2390\u20136.","journal-title":"J Clin Oncol"},{"key":"2318_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/pbc.21753","volume":"52","author":"TC Griffin","year":"2009","unstructured":"Griffin TC, Weitzman S, Weinstein H, et al. A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent\/refractory B-cell(CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's oncology group. Pediatr Blood Cancer. 2009;52:177\u201381.","journal-title":"Pediatr Blood Cancer"},{"key":"2318_CR21","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1200\/JCO.2003.08.151","volume":"21","author":"K Seidemann","year":"2003","unstructured":"Seidemann K, Tiemann M, Lauterbach I, et al. Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the berlin-Frankfurt-Munster group. J Clin Oncol. 2003;21:1782\u20139.","journal-title":"J Clin Oncol"},{"key":"2318_CR22","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1182\/blood-2012-04-422709","volume":"121","author":"M Gerrard","year":"2013","unstructured":"Gerrard M, Waxman IM, Sposto R, et al. Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB\/LMB96 mature B-NHL therapy. Blood. 2013;121:278\u201385.","journal-title":"Blood"},{"key":"2318_CR23","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1056\/NEJMc1305983","volume":"369","author":"W Woessmann","year":"2013","unstructured":"Woessmann W, Lisfeld J, Burkhardt B, et al. Therapy in primary mediastinal B-cell lymphoma. N Engl J Med. 2013;369:282.","journal-title":"N Engl J Med"},{"key":"2318_CR24","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1200\/JCO.1993.11.6.1024","volume":"11","author":"JR Anderson","year":"1993","unstructured":"Anderson JR, Jenkin RD, Wilson JF, et al. Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin\u2019s lymphoma: a report of CCG-551 from the Childrens cancer group. J Clin Oncol. 1993;11:1024\u201332.","journal-title":"J Clin Oncol"},{"key":"2318_CR25","first-page":"416","volume":"95","author":"A Reiter","year":"2000","unstructured":"Reiter A, Schrappe M, Ludwig WD, et al. Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood. 2000;95:416\u201321.","journal-title":"Blood"},{"key":"2318_CR26","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1200\/JCO.2005.02.2707","volume":"24","author":"B Burkhardt","year":"2006","unstructured":"Burkhardt B, Woessmann W, Zimmermann M, et al. Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma. J Clin Oncol. 2006;24:491\u20139.","journal-title":"J Clin Oncol"},{"key":"2318_CR27","doi-asserted-by":"publisher","unstructured":"Termuhlen AM, Smith LM, Perkins SL, et al. Outcome of newly diagnosed children and adolescents with localized lymphoblastic lymphoma treated on children\u2019s oncology group trial A5971: a report from the children\u2019s oncology group. Pediatr Blood Cancer. 2012;59:1229.","DOI":"10.1002\/pbc.24149"},{"key":"2318_CR28","doi-asserted-by":"publisher","unstructured":"Termuhlen AM, Smith LM, Perkins SL, et al. Disseminated lymphoblastic lymphoma in children and adolescents: results of the COG A5971 trial: a report from the children's oncology group. Br J Haematol. 2013;162:792.","DOI":"10.1111\/bjh.12460"},{"key":"2318_CR29","doi-asserted-by":"publisher","unstructured":"Burkhardt B, Reiter A, Landmann E, et al. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the Berlin-Frankfurt-Muenster group. J Clin Oncol. 2009;27:3363\u20139.","DOI":"10.1200\/JCO.2008.19.3367"},{"key":"2318_CR30","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/(SICI)1096-911X(199903)32:3<225::AID-MPO12>3.0.CO;2-N","volume":"32","author":"FH Kung","year":"1999","unstructured":"Kung FH, Harris MB, Krischer JP. Ifosfamide\/carboplatin\/etoposide (ICE), an effective salvaging therapy for recurrent malignant non-Hodgkin lymphoma of childhood: a pediatric oncology group phase II study. Med Pediatr Oncol. 1999;32:225\u20136.","journal-title":"Med Pediatr Oncol"},{"key":"2318_CR31","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1200\/JCO.2005.03.426","volume":"23","author":"SL Berg","year":"2005","unstructured":"Berg SL, Blaney SM, Devidas M, et al. Phase II study of nelarabine (compound506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's oncology group. J Clin Oncol. 2005;23:3376\u201382.","journal-title":"J Clin Oncol"},{"key":"2318_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3109\/07357909709115760","volume":"15","author":"TP Kaufmann","year":"1997","unstructured":"Kaufmann TP, Coleman M, Nisce LZ. Ki-1 skin lymphoproliferative disorders: management with radiation therapy. Cancer Investig. 1997;15:91\u20137.","journal-title":"Cancer Investig"},{"key":"2318_CR33","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0190-9622(96)90442-9","volume":"34","author":"EC Vonderheid","year":"1996","unstructured":"Vonderheid EC, Sajjadian A, Kadin ME. Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders. J Am Acad Dermatol. 1996;34:470\u201381.","journal-title":"J Am Acad Dermatol"},{"key":"2318_CR34","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1200\/JCO.2008.18.1487","volume":"27","author":"L Brugi\u00e8res","year":"2009","unstructured":"Brugi\u00e8res L, Le Deley MC, Rosolen A, et al. Impact of the methotrexate administration dose on the need for intrathecal treatment in children and adolescents with anaplastic large-cell lymphoma: results of a randomized trial of the EICNHL group. J Clin Oncol. 2009;27:897\u2013903.","journal-title":"J Clin Oncol"},{"key":"2318_CR35","first-page":"532","volume":"49","author":"SD Banavali","year":"2007","unstructured":"Banavali SD, Arora B, Vora T, et al. Vinblastine improves outcome in children with anaplastic large cell lymphoma (ALCL) treated with a uniform short duration intensive protocol. SIOP XXXIX meeting Abstracts PJ038. Pediatr Blood Cancer. 2007;49:532.","journal-title":"Pediatr Blood Cancer"},{"key":"2318_CR36","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1200\/JCO.2005.11.075","volume":"23","author":"JH Laver","year":"2005","unstructured":"Laver JH, Kraveka JM, Hutchison RE, et al. Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a pediatric oncology group phase III trial. J Clin Oncol. 2005;23:541\u20137.","journal-title":"J Clin Oncol"},{"key":"2318_CR37","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pbc.20121","volume":"44","author":"A Attarbaschi","year":"2005","unstructured":"Attarbaschi A, Dworzak M, Steiner M, et al. Outcome of children with primary resistant or relapsed non-Hodgkin lymphoma and mature B-cell leukemia afterintensive first-line treatment: a population-based analysis of the Austrian cooperative study group. Pediatr Blood Cancer. 2005;44:70\u20136.","journal-title":"Pediatr Blood Cancer"},{"key":"2318_CR38","doi-asserted-by":"publisher","unstructured":"Woessmann W, Zimmermann M, Lenhard M, et al. Relapsed or refractory anaplastic large-cell lymphoma in children and adolescents after Berlin-Frankfurt-Muenster (BFM)-type first-line therapy: a BFM-group study. J Clin Oncol. 2011;29:3065\u201371.","DOI":"10.1200\/JCO.2011.34.8417"},{"key":"2318_CR39","doi-asserted-by":"publisher","first-page":"5056","DOI":"10.1200\/JCO.2008.20.1764","volume":"27","author":"L Brugieres","year":"2009","unstructured":"Brugieres L, Pacquement H, Le Deley M-C, et al. Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Paediatric Oncology. J Clin Oncol. 2009;27:5056\u201361.","journal-title":"J Clin Oncol"},{"key":"2318_CR40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1023\/A:1008352726155","volume":"11","author":"L Brugi\u00e8res","year":"2000","unstructured":"Brugi\u00e8res L, Quartier P, LeDeley MC, et al. Relapses of childhood anaplastic large-cell lymphoma: treatment results in a series of 41 children--a report from the French Society of Pediatric Oncology. Ann Oncol. 2000;11:53\u20138.","journal-title":"Ann Oncol"},{"key":"2318_CR41","doi-asserted-by":"publisher","unstructured":"Woessmann W, Peters C, Lenhard M, et al. Allogeneic haematopoietic stem cell transplantation in relapsed or refractory anaplastic large cell lymphoma of children and adolescents--a Berlin-Frankfurt-M\u00fcnster group report. Br J Haematol. 2006;133:176\u201382.","DOI":"10.1111\/j.1365-2141.2006.06004.x"},{"key":"2318_CR42","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1200\/JCO.2011.38.0402","volume":"30","author":"B Pro","year":"2012","unstructured":"Pro B, Advani R, Brice P, et al. Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study. J Clin Oncol. 2012;30:2190\u20136.","journal-title":"J Clin Oncol"},{"key":"2318_CR43","doi-asserted-by":"publisher","unstructured":"Moss\u00e9 YP, Lim MS, Voss SD, et al. Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a children's oncology group phase 1 consortium study. Lancet Oncol. 2013;14:472\u201380.","DOI":"10.1016\/S1470-2045(13)70095-0"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-017-2318-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12098-017-2318-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-017-2318-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T00:03:31Z","timestamp":1601856211000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12098-017-2318-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["2318"],"URL":"https:\/\/doi.org\/10.1007\/s12098-017-2318-0","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,5]]}}}